AstraZeneca News and Research

RSS
Owlstone Medical named Medtech Company of the Year

Owlstone Medical named Medtech Company of the Year

New inhibitor could hold key to treating Acute Respiratory Distress Syndrome

New inhibitor could hold key to treating Acute Respiratory Distress Syndrome

Diabetes medication reduces risk of heart failure hospitalization

Diabetes medication reduces risk of heart failure hospitalization

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Presence of rare mutations indicates increased risk from interval breast cancers

Presence of rare mutations indicates increased risk from interval breast cancers

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Study: Targeting specific genomic mutation in breast cancer improves survival

Study: Targeting specific genomic mutation in breast cancer improves survival

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Cornell dots equipped with antibody fragments offer a new cancer weapon

Cornell dots equipped with antibody fragments offer a new cancer weapon

New pre-clinical research shows utility of mRNA platform to treat rare metabolic disorders

New pre-clinical research shows utility of mRNA platform to treat rare metabolic disorders

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

New Prosperity Partnerships projects that link research with industry unveiled

New Prosperity Partnerships projects that link research with industry unveiled

Non-small cell lung cancer patients survive longer when treated with durvalumab

Non-small cell lung cancer patients survive longer when treated with durvalumab

NIRS-IVUS imaging identifies patients and plaques vulnerable to subsequent adverse cardiac events

NIRS-IVUS imaging identifies patients and plaques vulnerable to subsequent adverse cardiac events

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

New research hub to drive radical change in development and manufacturing of vaccines

New research hub to drive radical change in development and manufacturing of vaccines